Quantification of MEG3 expression in a larger, independent cohort of patients showed significant upregulation (p = 0.0049) of MEG3 in MDS/AML-MRC patients compared to healthy donors (Figure 3A). Here, MEG3 is linked to myelodysplastic syndrome.